Breaking News
Sort by:
Top Post
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Pheno Therapeutics Announces Worldwide License from UCB to a Novel Program for Neurodegenerative Disease
Pheno Therapeutics, a biotechnology company focused on the discovery and development of small molecule therapeutics […]
JanOne Completes Acquisition of Soin Therapeutics
JanOne, a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced […]
Vistagen to Acquire Pherin Pharmaceuticals
Vistagen, a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living […]
KKR to Acquire Bushu Pharmaceuticals
KKR, a leading global investment firm, and Bushu Pharmaceuticals have announced the signing of definitive […]
SynAct Pharma to Make Strategic Acquisition of Swiss Biotech Company TXP Pharma
SynAct Pharma AB has announced that the company has entered into a conditional agreement on […]
Molecular Devices Acquires Cellesce, Expanding Industrywide Accessibility to Organoids
Molecular Devices, a leading provider of high-performance life science solutions, has announced the acquisition of […]
Abiogen Pharma Acquires German Pharmaceutical Company, Altamedics
Abiogen Pharma has completed the acquisition of the German pharmaceutical distribution company Altamedics GmbH which […]
Essential Pharma Announces the Acquisition of HALDOL
Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access […]
Medical Mutual Finalizes Acquisition of Reserve National Insurance Company
On Dec. 1, 2022, Medical Mutual closed on the acquisition of Reserve National Insurance Company, […]
Inszone Insurance Services Completes Acquisition of Kirsch Insurance Group
Inszone Insurance Services, a rapidly growing, national provider of benefits, personal and commercial lines insurance, […]
- Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Read more
- Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Read more
- Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Read more
- Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Read more
- Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Read more